Generate Biomedicines, Inc. (GENB) Insider Trading -- Recent Executive & Director Transactions

20 insiders reported 129 Form 4 transactions for Generate Biomedicines, Inc. (GENB) over the past 18 months (most recent 2026-09-03). Recent activity: ARNOLD FRANCES (Director) Sell 1,000 shares, Nally Michael (Chief Executive Officer) Buy 20,000 shares, Flagship Pioneering Fund VI, L.P. (10% Owner) Buy 13.7M shares, Bancel Stephane (Director) Buy 724,160 shares, AFEYAN NOUBAR (Director) Buy 12.7M shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-09-03ARNOLD FRANCESDirectorSell1,000$16,002
2026-03-06Nally MichaelChief Executive OfficerBuy20,000$240,000
2026-03-02Flagship Pioneering Fund VI, L.P.10% OwnerBuy13.7M$0
2026-03-02Bancel StephaneDirectorBuy724,160$0
2026-03-02AFEYAN NOUBARDirectorBuy12.7M$0
2026-03-02Flagship Pioneering Fund VI, L.P.10% OwnerBuy12.7M$0
2026-03-02Flagship VentureLabs VI LLC10% OwnerBuy12.7M$0
2026-03-02Flagship Pioneering Special Opportunities Fund II, L.P.10% OwnerBuy12.7M$0
2026-03-02Nutritional Health LTP Fund, L.P.10% OwnerBuy12.7M$0
2026-03-02Flagship Pioneering Fund VII, L.P.10% OwnerBuy12.7M$0
2026-03-02FPN II, L.P.10% OwnerBuy12.7M$0
2026-03-02AFEYAN NOUBARDirectorBuy13.7M$0
2026-03-02Nally MichaelChief Executive OfficerBuy658,327$0
2026-03-02Flagship VentureLabs VI LLC10% OwnerBuy13.7M$0
2026-03-02Flagship Pioneering Special Opportunities Fund II, L.P.10% OwnerBuy13.7M$0
2026-03-02Nutritional Health LTP Fund, L.P.10% OwnerBuy13.7M$0
2026-03-02Flagship Pioneering Fund VII, L.P.10% OwnerBuy13.7M$0
2026-03-02FPN II, L.P.10% OwnerBuy13.7M$0
2026-03-02AFEYAN NOUBARDirectorBuy987,491$0
2026-03-02Flagship Pioneering Fund VI, L.P.10% OwnerBuy987,491$0
2026-03-02Flagship VentureLabs VI LLC10% OwnerBuy987,491$0
2026-03-02Flagship Pioneering Special Opportunities Fund II, L.P.10% OwnerBuy987,491$0
2026-03-02Nutritional Health LTP Fund, L.P.10% OwnerBuy987,491$0
2026-03-02Flagship Pioneering Fund VII, L.P.10% OwnerBuy987,491$0
2026-03-02FPN II, L.P.10% OwnerBuy987,491$0

来源:SEC Form 4 申报文件 · 截至 2026-09-03